Centene

CNC

Market cap $29.4B

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

PBI, CNC and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 28, 2026.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

"America's Best Customer Service in Financial Services 2026" award recognizes companies delivering strong customer service based on nationwide consumer feedback SACRAMENTO, Calif., May 26, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), has been named one of America's Best Customer Service in Financial Services 2026, a national recognition published by USA TODAY in partnership with independent research firm Plant‑A Insights Group.

CNC, SANM and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 26, 2026.

The first quarter proved to be a boon for many major US managed care insurers, as earnings results exceeded consensus estimates, leading to rises in stock prices and higher full-year earnings estimates. The Centers for Medicare & Medicaid Services released higher-than-expected 2027 rates for Medicare Advantage plans that are aimed at seniors, assuaging some investor concerns.

U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.

The funding is made available through an annual program that addresses barriers to healthcare. AUSTIN, Texas, May 12, 2026 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), has announced the 2026 recipients of its annual grant program.

Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.

Here is how Centene (CNC) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year.